Nuvalent Inc - Class A — Cash Flow (NASDAQ:NUVL) | MetaTrader

Open full chart

Financials

Overview 성명 Statistics Dividends

Quarterly Annual

Cash from operating activities 40 M64.97 M99.74 M185.06 M275.21 M 275.21 M Cash from investing activities 220.03 M10.66 M143.53 M573.51 M124.08 M 124.08 M Cash from financing activities 318.22 M248.92 M336.85 M568.88 M515.34 M 515.34 M Free cash flow 40 M64.97 M99.74 M185.06 M275.21 M 275.21 M

뉴스

뉴밸런트, 4분기 손실 보고...폐암 치료제 FDA 결정 대기

Nuvalent reports Q4 loss, awaits FDA decision on lung cancer drug

Drugmakers turn to AI to speed trials, regulatory submissions

Nuvalent, 52주 신고가 경신…112.89 USD 기록

Nuvalent Inc stock hits 52-week high at 112.89 USD

FDA, 뉴발렌트의 ROS1 양성 NSCLC 치료제 NDA 접수

FDA accepts Nuvalent’s NDA for ROS1-positive NSCLC treatment

Nuvalent (NUVL) chief legal officer Miller sells $676k in stock

Nuvalent CSO Pelish sells shares worth $501,752

Nuvalent (NUVL) chief development officer sells $721k in stock

What's Going On With Royalty Pharma Stock Wednesday? - Royalty Pharma (NASDAQ:RPRX)

3 Biotech Stocks With Major 2026 Catalysts